Related references
Note: Only part of the references are listed.Elevated Circulating Endocan Levels Are Associated with Increased Levels of Endothelial and Inflammation Factors in Postprandial Lipemia
Serap Ozer Yaman et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension
M. Can et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)
Endocan: A Key Player of Cardiovascular Disease
Jinzhi Chen et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
The Association Between Serum Endocan Level and Short-Term Prognosis of Patients With Acute Ischemic Stroke
Feng Han et al.
ANGIOLOGY (2022)
Blood and aqueous humor phoenixin, endocan and spexin in patients with diabetes mellitus and cataract with and without diabetic retinopathy
Fatih Celik et al.
PEPTIDES (2022)
Diagnostic and Prognostic Protein Biomarkers of β-Cell Function in Type 2 Diabetes and Their Modulation with Glucose Normalization
Abu Saleh Md Moin et al.
METABOLITES (2022)
SERUM ENDOCAN LEVELS IN RELATION TO TRADITIONAL AND NON-TRADITIONAL ANTHROPOMETRIC INDICES IN ADULT POPULATION
Aleksandra Klisic et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2021)
Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention
Mustafa Dogdus et al.
ANGIOLOGY (2021)
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
Mohammed Altigani Abdalla et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2021)
Increased Carotid Intima-Media Thickness and Endothelial Cell-Specific Molecule-1 (Endocan) Levels in Obese Children
Aysin Nalbantoglu et al.
ANGIOLOGY (2021)
The relation of endocan and galectin-3 with ST-segment resolution in patients with ST-segment elevation myocardial infarction
Yasar Turan et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
Hande Erman et al.
MEDIATORS OF INFLAMMATION (2020)
Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases
Joao Bessa et al.
CLINICA CHIMICA ACTA (2020)
Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Metformin Effect on Endocan Biogenesis in Human Endothelial Cells Under Diabetic Condition
Elmira Zolali et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension
Sevil Fisekci Oktar et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2019)
Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome
Mojtaba Ziaee et al.
ANGIOLOGY (2019)
The Relationship Between Serum Endocan Level and Aortic Elastic Properties in Patients With Newly Diagnosed Essential Hypertension
Mustafa Celik et al.
ANGIOLOGY (2019)
Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat
Abdelaal M. Elkamshoushi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2019)
Relationship between Plasma Endocan Level and Clinical Outcome of Chinese Peritoneal Dialysis Patients
Peter Yam-Kau Poon et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus
Betul Ekiz-Bilir et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus
Aleksandra Klisic et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2018)
Biochemical markers of hypertension, prehypertension
L. Turgunova et al.
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE (2018)
Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke
Xin-Wei He et al.
CLINICA CHIMICA ACTA (2018)
Endocan Concentration in Patients With Primary Hypertension
Dominika Musialowska et al.
ANGIOLOGY (2018)
Does endocan level increase in women with polycystic ovary syndrome? A case - control study
Ilhan Bahri Dellbas et al.
GINEKOLOGIA POLSKA (2018)
Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus
Ilhan Balamir et al.
ANGIOLOGY (2018)
Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation: A Pilot Study
Chong-Rong Qiu et al.
ANGIOLOGY (2017)
Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome
Merve Bicer et al.
ENDOCRINE RESEARCH (2017)
P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease
Ala Ustyol et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)
Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk
Kirstine J. Belongie et al.
PLOS ONE (2017)
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study
Marcello Dallio et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2017)
Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus
Yaya Lv et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study
Yucel Arman et al.
ANGIOLOGY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim
Adem Gungor et al.
ENDOCRINE RESEARCH (2016)
Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome
Iclal Halici et al.
PEDIATRICS INTERNATIONAL (2016)
Endocan expression is increased in the placenta from obese women with gestational diabetes mellitus
Padma Murthi et al.
PLACENTA (2016)
Endocan and albuminuria in type 2 diabetes mellitus
Mehmet Ali Cikrikcioglu et al.
RENAL FAILURE (2016)
Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension
Tolga Cimen et al.
KOREAN CIRCULATION JOURNAL (2016)
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
Shunquan Wu et al.
SCIENTIFIC REPORTS (2016)
The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus
Ichiro Wakabayashi et al.
CLINICA CHIMICA ACTA (2015)
Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
Xiang-sheng Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension
Chang Xiong et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan
Turgay Celik et al.
BLOOD PRESSURE (2015)
The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor
Ahmed M. Abu El-Asrar et al.
CURRENT EYE RESEARCH (2015)
Endocan: A new marker for cancer and a target for cancer therapy
Jinghui Yang et al.
BIOMEDICAL REPORTS (2015)
Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study
Sevket Balta et al.
ANGIOLOGY (2014)
Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo
Wonhwa Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease
Elzafir Elsheikh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2014)
Mitochondrial Adaptations and Dysfunctions in Nonalcoholic Fatty Liver Disease
Karima Begriche et al.
HEPATOLOGY (2013)
Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
A. Cas et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2013)
Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity
J Janke et al.
HORMONE AND METABOLIC RESEARCH (2006)
Share Paper
